Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapyJ. E. Wraith, J Zeman, Maurizio Scarpa et al.|European Journal of Pediatrics|2007Cited by 522
Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension studyPaul Harmatz, Stuart J. Swiedler, Roberto Giugliani et al.|The Journal of Pediatrics|2006Cited by 364
Immunologic Privilege in the Central Nervous System and the Blood–Brain BarrierLeslie L. Muldoon, Edward A. Neuwelt, Jorge I. Alvarez et al.|Journal of Cerebral Blood Flow & Metabolism|2012Cited by 307
Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and managementElizabeth Braunlin, Roberto Giugliani, Paul Harmatz et al.|Journal of Inherited Metabolic Disease|2011Cited by 302
Possible strategies to cross the blood–brain barrierCinzia Maria Bellettato, Maurizio Scarpa|The Italian Journal of Pediatrics/Italian journal of pediatrics|2018Cited by 255